Whole-brain radiation therapy (WBRT)

RADIATION2 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions

Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain

Phase 1

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

CompletedNCT01703507

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityRecurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain

Start: 2012-11-09End: 2018-04-11Updated: 2025-05-16

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

WithdrawnNCT02145910

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityRecurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain

Updated: 2025-05-02

Related Papers

Phase I Study of Ipilimumab Combined with Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients with Brain Metastases

JHN journal2018-01-015 citations

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

2017-05-2690 citations